OPHTAL
19MG/ML+0,1MG/ML OPH AQA 4X25ML
| SÚKL code | 0201452 |
|---|---|
| Name of the product | OPHTAL |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | OPHTAL |
| Supplement | 19MG/ML+0,1MG/ML OPH AQA 4X25ML |
| Strenght | 19MG/ML+0,1MG/ML |
| Pharmaceutical form | Eye lotion |
| Package | 4X25ML |
| Route | Ocular use |
| Language of the pack | Czech |
| Wrap type | Dropper container |
| Legal status | OTC medicinal products |
| Active substance |
BORIC ACID (ACIDUM BORICUM) BENZODODECINIUM BROMIDE SOLUTION 10 PER CENT (BENZODODECINII BROMIDI SOLUTIO 10%) |
| ATC group | S01AX |
| ATC group name | JINÁ ANTIINFEKTIVA |
Marketing authorisation information
| Registration Number | 64/ 525/69-C |
|---|---|
| Type of MA | National |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 30. 04. 2020 |
| MA Holder | TEVA Czech Industries s.r.o., Opava-Komárov |
| MA Holder country | ČESKÁ REPUBLIKA |
| Actual MA holder | Teva B.V., Haarlem |
| Actual MA holder country | NIZOZEMSKO |
cz